EBS stock gains as first participant dosed in trial for Lassa virus vaccine (NYSE:EBS)
Tasos Katopodis/Getty Visuals Information Emergent BioSolutions Inc. (NYSE:EBS), a company identified for its agreement producing do the job, announced Tuesday...